[LXRX] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
10-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -10.76%
YoY- -366.08%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 39 35 37 14 23 234 27 27.75%
PBT -23,387 -24,587 -23,476 -25,611 -23,122 -18,067 -20,958 7.57%
Tax 292 580 96 -14 -90 19 48 232.87%
NP -23,679 -25,167 -23,572 -25,611 -23,122 -18,067 -20,958 8.47%
Tax Rate - - - - - - - -
Total Cost 23,718 25,202 23,609 25,625 23,145 18,301 20,985 8.49%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -60,715.38 -71,905.71 -63,708.11 -182,935.71 -100,530.43 -7,720.94 -77,622.22 -15.09%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.14 -0.17 -0.16 -0.17 -0.16 -0.13 -0.15 -4.49%
EPS Diluted -0.14 -0.17 -0.16 -0.17 -0.16 -0.13 -0.15 -4.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.